Home Your basket
• Adenocarcinoma of the eth...
   Price 8.50 €
• Vibration induced nystagm...
   Price 10.50 €
• Allergic and pneumologic ...
   Price 8.50 €
• Prospective evaluation of...
   Price 10.50 €
• Amphicrine adenoma of the...
   Price 8.50 €
• Migrating esophageal fore...
   Price 5.50 €
• Aesthetic profiloplasty: ...
   Price 10.50 €
• The European Evaluation o...
   Price 8.50 €
• Formant structures of vow...
   Price 10.50 €
• Vertical extended hemi cr...
   Price 5.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Mucormycosis – early diag...
   Price 10.50 €
• Peptide receptor radionuc...
   Price 14.00 €
• Otoplasty: Special attent...
   Price 8.50 €
• Giant laryngeal sarcomato...
   Price 12.00 €
• A specific plain X-ray in...
   Price 8.50 €
• Silent Sinus Syndrome – T...
   Price 8.50 €
• Non-traumatic nasal septa...
   Price 8.50 €
• Long-term results of faci...
   Price 10.50 €
• Partial hearing recovery ...
   Price 5.50 €
• The “Deglutition Handicap...
   Price 10.50 €
• Posterior cranial fossa a...
   Price 8.50 €
• Radiofrequency inferior t...
   Price 14.00 €
• Callas or the trajectory ...
   Price 10.50 €
• Ectopic thyroid basi-ling...
   Price 10.50 €
• Develop­ment of an osteos...
   Price 8.50 €
• Influence of phonetic con...
   Price 10.50 €
• Context influence on the ...
   Price 10.50 €
• Personal experience about...
   Price 10.50 €
• Assessing efficacy of voi...
   Price 5.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Bilateral abductor vocal ...
   Price 14.00 €
• ...
   Price 5.50 €
• Vocal and behavioral adap...
   Price 10.50 €
• Oto-rhino-laryngology and...
   Price 10.50 €
• The tensegrity concept ap...
   Price 10.50 €
• Identification and locali...
   Price 8.50 €
• Evaluation of a dysphonic...
   Price 10.50 €
• External otitis...
   Price 8.50 €
• Innovations in interventi...
   Price 15.00 €
• Vocal forcing and posture...
   Price 10.50 €
• The EXIT procedure: Princ...
   Price 8.50 €

Total Order 399.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2004 o

OTONEUROLOGY

Delayed facial palsy after vestibular schwannoma resection: The role of viral reactivation. Our experience in 8 cases


Authors : D.-Q. Nguyen, V. Franco-Vidal, J. Guérin, V. Darrouzet (Bordeaux)

Ref. : Rev Laryngol Otol Rhinol. 2004;125,1:23-29.

Article published in french
Downloadable PDF document french



Summary : Objective: To study the role of herpes virus reactivation in the onset of more than three days-delayed facial paralysis (FP) following vestibular schwannoma (VS) surgery and advocate a specific medical management. Material and Methods: Retrospective study on 8 cases from a series of 348 patients operated on of a VS between 1996 and 2002. Seven of the eight patients were given intravenously acyclovir (30 mg.kg-1.d-1 for 5 days) and methyl-prednisolone (2 mg.kg-1.d-1 for 7 days). A serologic testing looking for specific anti-herpes simplex viruses type 1 and 2 (HSV-2) and varicella-zoster virus (VZV) antibodies at the onset of the FP and 2 weeks later could be done in only 3 cases. Results: Mean delay of FP onset was 8.75 days. Mean time for recovery with intravenous treatment was 90 days. All treated patients had a House and Brackmann grade 1 recovery. The last one had only a grade 3 after 400 days of evolution: he could not be treated because of postoperative transient psychiatric problems. Serologic testing revealed in those patients in whom it could be done either a high level of anti-HSV or –VZV antibodies at the time of onset or a dramatic increase in anti-HSV or anti-VZV antibodies between the two samples, strongly suggesting a HSV or VZV reactivation. Conclusion: HSV or VZV reactivation can be evocated in most cases of delayed FPs arising in the postoperative course of VSs, suggesting usefulness of emergency-given steroid and acyclovir intravenous regimen to block virus replication and fight secondary oedema and inflammation causative of nerve lesions. Evoked reactivation mechanism is comparable to that already suspected in delayed FP arising with the same delay in middle ear surgical procedures.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE